Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma

Author: Chipps Bradley E.   Figliomeni Maria   Spector Sheldon  

Publisher: OceanSide Publications, Inc

ISSN: 1539-6304

Source: Allergy and Asthma Proceedings, Vol.33, Iss.5, 2012-09, pp. : 377-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content